08.01.2013
- Celgene on Monday forecast 2013 profit in line with Wall Street projections, introduced a long-term outlook for 2017, and said results from two late-stage trials of a drug for the...
05.01.2013
- A measure to require special labeling of genetically modified foods appeared virtually certain to qualify for the ballot in Washington state on Friday, two months after voters in...
04.01.2013
- Italian biopharmaceutical company Philogen has signed a worldwide license agreement with drug firm Pfizer for the development of Dekavil, an experimental treatment for autoimmune...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
21.12.2012
- Roche is to join forces with Japan's PSS to improve its gene sequencing process, raising investment in its own technology after dropping a $6.8 billion bid for sequencing market...
20.12.2012
- A federal judge on Wednesday approved a $762 million payment from Amgen, the final step to resolve nearly a dozen criminal and civil cases stemming from the sale of its once...
18.12.2012
- Amgen pleaded guilty in a federal court in New York on Tuesday to misbranding its Aranesp anemia drug and agreed to pay $762 million in a civil settlement and criminal fines. The...
13.12.2012
- Print edition as epaper. Europe 04 Germany´s Chemical Parks Investing in a Unique Range of Economic Benefits 06 Healthy German-Saudi Cooperation 08 Global Meets Local in Austria...
12.12.2012
- Russian billionaire Yuri Milner, best-known for investments linking consumers to the Internet, is placing a bet on genetics. Milner, who backed companies ranging from Facebook to...
10.12.2012
- U.S. biotechnology group Amgen has agreed to buy unlisted Decode Genetics, a pioneer in gene research, for $415 million to boost its drive to develop better targeted drugs. Founded...
